Basic Information
Glycart Biotechnology AG researches, develops, and commercializes novel potent antibody products for the treatment of unmet clinical needs, such as cancer.
Glycart Biotechnology AG
Zurich,Zurich,Switzerland
15~50 people
January 01, 2000
--